New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.
about
EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitorsHuman Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionOptimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells.Pharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery.Identification of Vimentin as a Potential Therapeutic Target against HIV InfectionTenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.An intravaginal ring for the simultaneous delivery of multiple drugs.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Testing anti-HIV activity of antiretroviral agents in vitro using flow cytometry analysis of CEM-GFP cells infected with transfection-derived HIV-1 NL4-3.Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy.HIV-1 CNS in vitro infectivity models based on clinical CSF samples.Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.
P2860
Q24606095-EBF3EE93-B296-40A6-918E-2D21F4D642FEQ26751304-329C5976-22E0-4AD3-8F6D-C8932A67EEC1Q34794784-21B1A029-FEAB-465B-8FE9-CDA9A225D6ECQ34922985-B900C471-E4BF-4E56-AC23-2EEF9DA5B947Q36173759-14853954-24D8-4ED5-8202-8E22C4767FF4Q36589574-E134F731-D00D-4D68-86FE-DE3413F0A77BQ37049947-97778797-1FF0-486A-BD11-45CF3A766959Q37373727-D3A58A07-C67A-41A2-BFD7-7B9A4DB6EA80Q37379716-1E77502D-8A29-4E27-8C82-A43B54B70458Q37835819-EAF61E34-64E3-4956-AA73-C59A7432FEEFQ38823335-C04924D4-EBAA-46F5-B4A9-D87A84089411Q38848973-903D4343-8E4E-4DDE-8228-EDED686E176FQ38952927-950415BF-56FF-44F2-8525-B7331FF2BCCDQ40880324-15C0F365-A721-443B-8503-35615AC60ED8
P2860
New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@en
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@nl
type
label
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@en
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@nl
prefLabel
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@en
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@nl
P2860
P1476
New approaches for quantitatin ...... al drugs in vitro and in vivo.
@en
P2093
Moira A McMahon
P2860
P304
P356
10.1097/QCO.0B013E328332C54D
P577
2009-12-01T00:00:00Z